Genolution Inc. Asset Resilience Ratio

Latest as of September 2025: 3.80%

Genolution Inc. asset resilience ratio. Genolution Inc. (225220) has an Asset Resilience Ratio of 3.80% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 225220 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩3.79 Billion

≈ $2.57 Million USD Cash + Short-term Investments

Total Assets

₩99.84 Billion

≈ $67.66 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Genolution Inc. (2016–2024)

Asset resilience ratio of Genolution Inc. from 2016 to 2024. This chart shows how Genolution Inc.'s Asset Resilience Ratio has changed over time. Read Genolution Inc. (225220) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Genolution Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Genolution Inc. balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩3.79 Billion	3.8%
Total Liquid Assets	₩3.79 Billion	3.80%

Asset Resilience Insights

Limited Liquidity: Genolution Inc. maintains only 3.80% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Genolution Inc. Industry Peers by Asset Resilience Ratio

Compare Genolution Inc.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Genolution Inc. Asset Resilience Ratio by Year (2016–2024)

Genolution Inc. asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Genolution Inc..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	31.20%	₩33.21 Billion ≈ $22.51 Million	₩106.45 Billion ≈ $72.14 Million	-6.49pp
2023-12-31	37.69%	₩42.75 Billion ≈ $28.97 Million	₩113.44 Billion ≈ $76.88 Million	-2.82pp
2022-12-31	40.51%	₩46.37 Billion ≈ $31.42 Million	₩114.45 Billion ≈ $77.56 Million	-7.87pp
2021-12-31	48.38%	₩45.93 Billion ≈ $31.13 Million	₩94.94 Billion ≈ $64.34 Million	-10.06pp
2020-12-31	58.44%	₩48.96 Billion ≈ $33.18 Million	₩83.77 Billion ≈ $56.77 Million	+30.02pp
2019-12-31	28.42%	₩3.82 Billion ≈ $2.59 Million	₩13.43 Billion ≈ $9.10 Million	-18.57pp
2018-12-31	46.99%	₩5.21 Billion ≈ $3.53 Million	₩11.10 Billion ≈ $7.52 Million	+1.21pp
2017-12-31	45.78%	₩2.15 Billion ≈ $1.46 Million	₩4.71 Billion ≈ $3.19 Million	-12.50pp
2016-12-31	58.28%	₩2.33 Billion ≈ $1.58 Million	₩3.99 Billion ≈ $2.71 Million	--

pp = percentage points

About Genolution Inc.

KQ:225220 Korea Biotechnology

Market Cap

$21.55 Million

₩31.80 Billion KRW

Market Cap Rank

#24712 Global

#1783 in Korea

Share Price

₩1760.00

Change (1 day)

+1.21%

52-Week Range

₩1030.00 - ₩2225.00

All Time High

₩10300.23